Terconazole/Metronidazole

特康唑/甲硝唑

Report date: 2022/11/21 10:52:57

Base Information

Drug NameTerconazole/Metronidazole
Drug Alias Name甲硝唑/特康唑Triaconazole/MetronidazoleMetronidazole/Terconazole
ClassificationSmall molecules
Mechanisms of ActionDNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsVaginitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes TerconazoleMetronidazole
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCuratek Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsVaginitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A